About Ebola, an app built using a programming platform developed in Israel and abroad, is providing medical workers in the field with what is turning out to be one of their most effective tools available for preventing the alarming spread of Ebola in the villages of in West Africa.

Although the ZMapp Ebola drug, which proved effective on infected American aid workers, has run out, Israeli company Protalix says it can produce more, if needed.